Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Critical Care Compendium1001 Topics in Intensive Care & Acute Medicine, pp. 493 - 498Publisher: Cambridge University PressPrint publication year: 2023
References
Bibliography
Bardin, PG, Van Eeden, SF, Moolman, JA, et al. Organophosphate and carbamate poisoning. Ann Intern Med 1994; 154: 1433.Google Scholar
Dunn, MA, Sidell, FR. Progress in medical defense against nerve agents. JAMA 1989; 262: 649.CrossRefGoogle ScholarPubMed
Eddleston, M, Szinicz, L, Eyer, P, et al. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. Quart J Med 2002; 95: 275.CrossRefGoogle ScholarPubMed
Emad, A, Rezaian, GR. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single heavy exposure. Chest 1997; 112: 734.CrossRefGoogle ScholarPubMed
Kvetan, V, Farmer, JC, et al., eds. Critical care medicine for disasters, terrorism, and military conflict. Crit Care Med 2005; 33 (1, suppl.).CrossRefGoogle Scholar
Leikin, JB, Thomas, RG, Walter, FG, et al. A review of nerve agents for the critical care physician. Crit Care Med 2002; 30: 2346.CrossRefGoogle ScholarPubMed
Mokhlesi, B, Leikin, JB, Murray, P, et al. Adult toxicology in critical care: part II: specific poisonings. Chest 2003; 123: 897.CrossRefGoogle ScholarPubMed
Nozaki, H, Aikawa, N, Shinozawa, Y, et al. Sarin poisoning in Tokyo subway. Lancet 1995; 345: 980.Google ScholarPubMed
Rickett, DL, Glenn, JF, Houston, WE. Medical defense against nerve agents: new directions. Milit Med 1987; 152: 35.CrossRefGoogle ScholarPubMed
Tafuri, J, Roberts, J. Organophosphate poisoning. Ann Emerg Med 1987; 16: 193.CrossRefGoogle ScholarPubMed
Vedder, EB. The Medical Aspects of Chemical Warfare. Baltimore: Williams & Wilkins. 1925.Google Scholar
Zimmerman, JL. Poisonings and overdoses in the intensive care unit: general and specific management issues. Crit Care Med 2003; 31: 2794.Google Scholar
Bibliography
Hamilton, D, Harris, MD, Foweraker, J, et al. Waterhouse–Friderichsen syndrome as a result of non-meningococcal infection. J Clin Pathol 2004; 57: 208.CrossRefGoogle ScholarPubMed
Vella, A, Nippoldt, TB, Morris, JC. Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc 2001; 76: 161.Google Scholar
Bibliography
Aries, PM, Lamprecht, P, Gross, WL. Biological therapies: new treatment options for ANCA-associated vasculitis? Expert Opin Biol Ther 2007; 7: 521.CrossRefGoogle ScholarPubMed
Beaty, MW, Toro, J, Sorbara, L, et al. Cutaneous lymphomatoid granulomatosis: correlation of clinical and biological features. Am J Surg Pathol 2001; 25: 1111.CrossRefGoogle Scholar
Cordier, JF, Valeyre, D, Gullevin, L, et al. Pulmonary Wegener’s granulomatosis. Chest 1990; 97: 906.Google Scholar
European Vasculitis Study Group. A mulicenter randomized trial of cyclophosphamide versus azathioprine during remission in ANCA-associated systemic vasculitis. Arthritis Rheum 1999; 42 (suppl.): 225.Google Scholar
Falk, RJ, Jennett, JC. Wegener’s granulomatosis, systemic vasculitis, and antineutrophil cytoplasmic autoantibodies. Annu Rev Med 1991; 42: 459.CrossRefGoogle ScholarPubMed
Fauci, AS, Haynes, BF, Costa, J, et al. Lymphomatoid granulomatosis. N Engl J Med 1982; 306: 68.CrossRefGoogle ScholarPubMed
Frankel, SK, Cosgrove, GP, Fischer, A, et al. Update in the diagnosis and management of pulmonary vasculitis. Chest 2006; 129: 452.CrossRefGoogle ScholarPubMed
Gatenby, PA. Anti-neutrophil cytoplasmic antibody-associated systemic vasculitis: nature or nurture? Intern Med J 2012; 42: 351.Google Scholar
Gomez-Puerta, JA, Hernandez-Rodriguez, J, Lopez-Soto, A, et al. Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease. Chest 2009; 136: 1101.CrossRefGoogle ScholarPubMed
Hagen, EC, Ballieux, BEPB, van Es, LA, et al. Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood 1993; 81: 1996.Google Scholar
Hoffman, G. Treatment of Wegener’s granulomatosis: time to change the standard of care? Arthritis Rheum 1997; 40: 2099.Google Scholar
Hoffman, GS, Specks, U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998; 41: 1521.Google Scholar
Kallenberg, C, Brouwer, E, Weening, J, et al. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994; 46: 1.Google Scholar
Ricketti, AJ, Greenberger, PA, Mintzer, RA, et al. Allergic bronchopulmonary aspergillosis. Arch Intern Med 1983; 143: 1553.Google Scholar
Salama, AD. Pathogenesis and treatment of ANCA-associated systemic vasculitis. J R Soc Med 1999; 92: 456.CrossRefGoogle ScholarPubMed
Bibliography
Doherty, MJ, Watson, NF, Uchino, K, et al. Diffusion abnormalities in patients with Wernicke encephalopathy. Neurology 2002; 58: 655.CrossRefGoogle ScholarPubMed
Harper, CG, Giles, M, Finlay-Jones, R. Clinical signs in the Wernicke-Korsakoff complex. J Neurol Neurosurg Psychiatry 1986; 49: 341.Google Scholar
Latt, N, Dore, G. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Intern Med J 2014; 44: 911.CrossRefGoogle ScholarPubMed
Reuler, JB, Girard, DE, Cooney, TG. Wernicke’s encephalopathy. N Engl J Med 1985; 312: 1035.Google Scholar
Bibliography
Campbell, GL, Marfin, AA, Lanciotti, RS, et al. West Nile virus. Lancet Infect Dis 2002; 2: 519.CrossRefGoogle ScholarPubMed
Hayes, EB, Sejvar, JJ, Zaki, SR, et al. Virology, pathology and clinical manifestations of West Nile virus disease. Emerg Infect Dis 2005; 11: 1174Google Scholar
Bibliography
Relman, DA, Schmidt, TM, MacDermott, RP, et al. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med 1992; 327: 293.Google Scholar
Swartz, MN. Whipple’s disease: past, present and future. N Engl J Med 2000; 342: 648.CrossRefGoogle Scholar